ResearcherWestern UniversityNo recent work listed

Nawab Azizi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1474-6543; OpenAlex author ID A5020140844. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper

Papers 1

Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. Co-author DOI 10.1038/s41388-021-01771-z ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nina G. Steele · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗
María Teresa Borrello · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗
Fatemeh Mousavi · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗
Marina Pasca di Magliano · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗
Jiaqi Shi · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗
Christopher L. Pin · 1 shared paper, 2021 · strength 0.12
- Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.